GLP-1 medications should not be taken by anyone with a personal history or family history of medullary thyroid cancer, as development of these tumors were noted during early animal studies
Maybe your insurance stopped covering it (one of the most common reasons people quit taking GLP-1 drugs like Ozempic or Zepbound)
Early Evidence In the latest GLP-1 study 2025 , orforglipron showed early promise for adults with obesity and those living with type 2 diabetes, especially at the highest evaluated dose
Disclaimer: This content is intended for educational and informational purposes only and does not substitute professional medical advice, diagnosis, or treatment
[DOI] [PubMed] [Google Scholar] 78.Li M., Meng N., Guo X., Niu X., Zhao Z., Wang W., Xie X., Lv P
Digestion